News for Legend Biotech Corporation (LEGN)

**media[549749]**

We recently published a list of the 10 Oversold Pharma Stocks to Buy According to Analysts.

Meridian Funds, managed by ArrowMark Partners, released its “Meridian Contrarian Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.

We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now.

We recently published a list of 10 Best Mid-Cap Growth Stocks to Buy According to Analysts.

On December 31, 2024, FMR LLC (Trades, Portfolio), a prominent investment firm, executed a significant reduction in its holdings of Legend Biotech Corp (NASDAQ:

We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Legend Biotech Corporation (NASDAQ:LEGN) stands against...

A lot is happening in the market, especially within the growth sectors.

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential.

Legend Biotech is a commercial-stage biotech company specializing in innovative cell therapies, with a strong pipeline and global R&D presence. Read more about Legend's plans in 2025.

PR NewswireNEWTON, Mass., Jan. 2, 2025 NEWTON, Mass., Jan. 2, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmace

25 US stocks for 2025: UBS's highest conviction calls

**media[496607]**

Legend Biotech’s Carvykti therapy is driving growth, supported by strong financials. Discover why LEGN stock has a bullish outlook from analysts.

We recently compiled a list of the 10 Best Up and Coming Stocks To Buy According to Analysts. In this article, we are going to take a look at where Legend Biotech Corp.

We recently compiled a list of the 10 Worst Performing Biotech Stocks in 2024. In this article, we are going to take a look at where Legend Biotech Corporation (NASDAQ:LEGN) stands against the other ...

RBC's top 10 questions and answers on biotech stocks

PISCATAWAY, N.J., Sept. 12, 2024 /PRNewswire/ -- GenScript Biotech Corporation ('GenScript'), a global leader in life sciences products and services, announced the appointment of Dr. Ross Allen Grossman as a Non-Executive Director and Dr. Alphonse Galdes as an Independent Non-Executive Director. These appointments not only further diversify the Group's Board but also highlight GenScript's commitment to building an international, diverse, and highly specialized corporate governance team. With the addition of these two directors, the company is better positioned to meet the challenges of a complex global landscape and governance requirements.

S&P futures vs fair value: -23.00. Nasdaq futures vs fair value: -125.00. The S&P 500 futures are down 23 points, trading 0.5% below fair valu